Antibiotics have made it possible to treat bacterial infections such as meningitis and
bacteraemia that, prior to their introduction, were untreatable and consequently fatal …

The management of carbapenem-resistant infections is often based on polymyxins,
tigecycline, aminoglycosides and their combinations. However, in a recent systematic …

Multidrug-resistant bacteria have on overwhelming impact on human health, as they cause
over 670,000 infections and 33,000 deaths annually in the European Union alone. Of these …

Until recently, the polymyxin antibiotics were used sparingly due to dose limiting toxicities.
However, the lack of therapeutic alternatives for infections caused by highly resistant Gram …

Background We evaluated the association between mortality and colistin resistance in
Acinetobacter baumannii infections and the interaction with antibiotic therapy. Methods This …

Fosfomycin is being increasingly prescribed for multidrug-resistant bacterial infections. In
patients with systemic involvement, intravenous fosfomycin is usually administered as a …

In view of the limitations of the current water droplet manipulation technology in liquid
environment, a new polyaniline and polyvinylidene fluoride nanowire-based triboelectric …

Cefiderocol (CFDC),(formerly S‐649266), is a novel injectable siderophore cephalosporin
developed by Shionogi & Co., Ltd., with potent in vitro activity against Gram‐negative …

The prevalence of acinetobacter baumannii (AB) as a cause of hospital infections has been
rising. Unfortunately, emerging colistin resistance limits therapeutic options and affects the …

The aim of this study was to determine the activity and synergistic mechanisms of resveratrol
in combination with chlorhexidine against carbapenem-resistant Acinetobacter baumannii …